Methyl 2-[[6-[methyl-(3-methyl-1H-indol-5-yl)carbamoyl]-2-morpholin-4-ylpyrimidin-4-yl]amino]acetate
C22H26N6O4 — CID 68513037
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[[6-[methyl-(3-methyl-1H-indol-5-yl)carbamoyl]-2-morpholin-4-ylpyrimidin-4-yl]amino]acetate
Methyl 2-[[6-[methyl-(3-methyl-1H-indol-5-yl)carbamoyl]-2-morpholin-4-ylpyrimidin-4-yl]amino]acetate (PubChem CID 68513037) has the molecular formula C22H26N6O4 and a molecular weight of 438.49 g/mol. Its IUPAC name is methyl 2-[[6-[methyl-(3-methyl-1H-indol-5-yl)carbamoyl]-2-morpholin-4-ylpyrimidin-4-yl]amino]acetate.
Molecular Properties
| Compound Name | Methyl 2-[[6-[methyl-(3-methyl-1H-indol-5-yl)carbamoyl]-2-morpholin-4-ylpyrimidin-4-yl]amino]acetate |
|---|---|
| PubChem CID | 68513037 |
| Molecular Formula | C22H26N6O4 |
| Molecular Weight | 438.49 g/mol |
| Exact Mass | 438.20 |
| IUPAC Name | methyl 2-[[6-[methyl-(3-methyl-1H-indol-5-yl)carbamoyl]-2-morpholin-4-ylpyrimidin-4-yl]amino]acetate |
| SMILES | COC(=O)CNc1cc(C(=O)N(C)c2ccc3[nH]cc(C)c3c2)nc(N2CCOCC2)n1 |
| InChI | InChI=1S/C22H26N6O4/c1-14-12-23-17-5-4-15(10-16(14)17)27(2)21(30)18-11-19(24-13-20(29)31-3)26-22(25-18)28-6-8-32-9-7-28/h4-5,10-12,23H,6-9,13H2,1-3H3,(H,24,25,26) |
| InChIKey | VZLKIXASYHWGGU-UHFFFAOYSA-N |
| XLogP | 1.96 |
| TPSA | 112.68 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.49 |
| LogP ≤ 5 | 1.96 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 68513037 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.